105 related articles for article (PubMed ID: 16099718)
1. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
Xyrem International Study Group
Sleep Med; 2005 Sep; 6(5):415-21. PubMed ID: 16099718
[TBL] [Abstract][Full Text] [Related]
2. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
[TBL] [Abstract][Full Text] [Related]
3. Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
Kushida CA; Shapiro CM; Roth T; Thorpy MJ; Corser BC; Ajayi AO; Rosenberg R; Roy A; Seiden D; Dubow J; Dauvilliers Y
Sleep; 2022 Jun; 45(6):. PubMed ID: 34358324
[TBL] [Abstract][Full Text] [Related]
4. Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy.
Dauvilliers Y; Lammers GJ; Lecendreux M; Maski K; Kansagra S; Black J; Parvataneni R; Chen A; Wang YG; Plazzi G
J Clin Sleep Med; 2024 Mar; 20(3):445-454. PubMed ID: 37942930
[TBL] [Abstract][Full Text] [Related]
5. Cataplexy response with extended-release once-nightly sodium oxybate: Post hoc responder analyses from the phase 3 REST-ON clinical trial.
Thorpy MJ; Kushida CA; Bogan R; Ajayi AO; Corser BC; Gudeman J
Sleep Med X; 2024 Dec; 7():100109. PubMed ID: 38601325
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study.
Bae CJ; Zee PC; Leary EB; Fuller DS; Macfadden W; Candler S; Steininger TL; Husain AM
Sleep Med; 2023 Sep; 109():65-74. PubMed ID: 37421868
[TBL] [Abstract][Full Text] [Related]
7. Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment.
Morse AM; Krahn L; Flygare J; Kushida C; Thorpy MJ; Athavale A; Gudeman J
Adv Ther; 2023 Jul; 40(7):3199-3216. PubMed ID: 37243863
[TBL] [Abstract][Full Text] [Related]
8. Dosing and transition characteristics in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study.
Husain AM; Zee PC; Leary EB; Fuller DS; Macfadden W; Candler S; Whalen M; Bae CJ
Sleep Med; 2024 Jan; 113():328-337. PubMed ID: 38103464
[TBL] [Abstract][Full Text] [Related]
9. Effects of oxybate dose and regimen on disrupted nighttime sleep and sleep architecture.
Roth T; Dauvilliers Y; Bogan RK; Plazzi G; Black J
Sleep Med; 2024 Feb; 114():255-265. PubMed ID: 38244463
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic interactions of a solid formulation of sodium oxybate and ethanol in healthy volunteers.
Pross N; Patat A; Vivet P; Bidaut M; Fauchoux N
Br J Clin Pharmacol; 2015 Sep; 80(3):480-92. PubMed ID: 25782469
[TBL] [Abstract][Full Text] [Related]
11. Mania-Like Reaction Secondary to Sodium Oxybate.
Cárdenes-Moreno C; Pérez-Sagaseta de Ilurdoz I; Yelmo-Cruz S; Tascón-Cervera JJ; Gallego-Restrepo M; González-Rodríguez GP; Del Rosario Cejas-Méndez M
J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):64-66. PubMed ID: 38100782
[No Abstract] [Full Text] [Related]
12. Individualized Treatment Patterns for Patients with Narcolepsy Treated with Oxybate: A Clinical Practice Perspective.
Roy A; Ito D; Morris S; Candler S; Profant J; Bae C
Nat Sci Sleep; 2023; 15():767-778. PubMed ID: 37799734
[TBL] [Abstract][Full Text] [Related]
13. Sodium Oxybate in Alcohol-Responsive Essential Tremor of Voice: An Open-Label Phase II Study.
O'Flynn LC; Frucht SJ; Simonyan K
Mov Disord; 2023 Oct; 38(10):1936-1944. PubMed ID: 37448353
[TBL] [Abstract][Full Text] [Related]
14. Letter to the Editor regarding: "Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary" by R. Rosenberg et al.
Roth T
Neurol Ther; 2024 May; ():. PubMed ID: 38795308
[No Abstract] [Full Text] [Related]
15. Sleep-related painful erections treated with sodium oxybate.
Chaudhary HS; Zeidman E; Punjani N; Tashman Y
J Clin Sleep Med; 2024 Mar; ():. PubMed ID: 38456812
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum to "Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study" [Sleep Med. 109 (2023) 65-74 ISSN 1389-9457].
Bae CJ; Zee PC; Leary EB; Fuller DS; Macfadden W; Candler S; Steininger TL; Husain AM
Sleep Med; 2024 Jul; 119():17-18. PubMed ID: 38631160
[No Abstract] [Full Text] [Related]
17. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
Xyrem International Study Group
J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
[TBL] [Abstract][Full Text] [Related]
18. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
Black J; Houghton WC
Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
[TBL] [Abstract][Full Text] [Related]
19. A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy.
Mamelak M; Swick T; Emsellem H; Montplaisir J; Lai C; Black J
Sleep Med; 2015 Jan; 16(1):52-8. PubMed ID: 25533539
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
